186 related articles for article (PubMed ID: 17932752)
1. Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis.
Leung Y; Panaccione R; Hemmelgarn B; Jones J
Dig Dis Sci; 2008 Jun; 53(6):1455-61. PubMed ID: 17932752
[TBL] [Abstract][Full Text] [Related]
2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Tsoulis DJ; Macdonald JK
Cochrane Database Syst Rev; 2012 Sep; (9):CD000478. PubMed ID: 22972046
[TBL] [Abstract][Full Text] [Related]
3. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; Patton PH; Chande N; McDonald JW; MacDonald JK
Cochrane Database Syst Rev; 2016 May; 2016(5):CD000478. PubMed ID: 27192092
[TBL] [Abstract][Full Text] [Related]
4. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.
Timmer A; McDonald JW; Macdonald JK
Cochrane Database Syst Rev; 2007 Jan; (1):CD000478. PubMed ID: 17253451
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
[TBL] [Abstract][Full Text] [Related]
6. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis].
Ohno K; Masunaga Y; Ogawa R; Hashiguchi M; Ogata H
Yakugaku Zasshi; 2004 Aug; 124(8):555-60. PubMed ID: 15297725
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Townsend CM; Parker CE; MacDonald JK
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Chande N; Tsoulis DJ; MacDonald JK
Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Khan KJ; Dubinsky MC; Ford AC; Ullman TA; Talley NJ; Moayyedi P
Am J Gastroenterol; 2011 Apr; 106(4):630-42. PubMed ID: 21407186
[TBL] [Abstract][Full Text] [Related]
10. [Azathioprine and 6-mercaptopurine for maintenance treatment in ulcerative colitis. A survey of a Cochrane review].
Bjerrum JT; Nielsen OH
Ugeskr Laeger; 2007 Dec; 169(50):4341-4. PubMed ID: 18211790
[No Abstract] [Full Text] [Related]
11. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Mertz Nielsen A; Theede K; Gluud LL; Kiszka-Kanowitz M
Scand J Gastroenterol; 2024 Jun; 59(6):669-673. PubMed ID: 38444060
[TBL] [Abstract][Full Text] [Related]
13. Thiopurine Treatment in Ulcerative Colitis: A Critical Review of the Evidence for Current Clinical Practice.
van Gennep S; de Boer NK; D'Haens GR; Löwenberg M
Inflamm Bowel Dis; 2017 Dec; 24(1):67-77. PubMed ID: 29272488
[TBL] [Abstract][Full Text] [Related]
14. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
15. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
[TBL] [Abstract][Full Text] [Related]
16. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
17. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
18. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
19. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
[TBL] [Abstract][Full Text] [Related]
20. Medical therapies for ulcerative colitis and Crohn's disease.
Baert FJ; Rutgeerts PJ
Curr Gastroenterol Rep; 2000 Dec; 2(6):446-50. PubMed ID: 11079045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
